Teleflex Incorporated last reported quarterly results on Aug 6, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $570.3 million (+28.9% year over year) and diluted EPS of $2.28. It usually reports 8–39 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 5, 2026.
Results for Q3 FY2026, the quarter ending around Sep 27, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Nov 6, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 8–39 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 6, 2026
37 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
570
+28.9%
|
100
-18.7%
|
2.28
-17.7%
|
|
May 7, 2026
37 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
548
+32.3%
|
-8
-108.6%
|
-0.18
-108.7%
|
|
Jan 8, 2026
8 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
569
+28.7%
|
-714
-422.7%
|
-16.15
-451.2%
|
|
Nov 6, 2025
39 days after quarter end
|
Q3 FY2025
ended Sep 28, 2025
|
567
+33.0%
|
-409
-468.4%
|
-9.24
-491.5%
|
|
Jul 31, 2025
32 days after quarter end
|
Q2 FY2025
ended Jun 29, 2025
|
443
+5.7%
|
123
+53.2%
|
2.77
+63.9%
|
|
May 1, 2025
32 days after quarter end
|
Q1 FY2025
ended Mar 30, 2025
|
414
+0.3%
|
95
+521.4%
|
2.07
+546.9%
|
|
Feb 27, 2025
58 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
442
+190.6%
|
-137
-539.3%
|
-2.93
-545.6%
|
|
Oct 31, 2024
32 days after quarter end
|
—
ended Sep 29, 2024
|
—
|
—
|
—
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TFX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wayne, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 96943
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.